טוען...
Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants
Despite successful treatments, hepatitis C virus (HCV) infections continue to be a significant world health problem. High treatment costs, the high number of undiagnosed individuals, and the difficulty to access to treatment, particularly in marginalized susceptible populations, make it improbable t...
שמור ב:
| הוצא לאור ב: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7350220/ https://ncbi.nlm.nih.gov/pubmed/32560440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8020313 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|